A new ADHD drug targets three brain chemicals instead of two. Here's what that means

🌐 Medical Xpress (IM) —
A new ADHD drug targets three brain chemicals instead of two. Here's what that means

AI Summary

Centanafadine, a new ADHD medication sold under the brand name Simtriyo, targets three brain chemicals instead of two, offering a novel treatment option for attention-deficit/hyperactivity disorder.

A new medicine for attention-deficit/hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-daily tablet sold under the brand name Simtriyo.

Markets Health ADHD medicine centanafadine Simtriyo brain chemicals treatment

Read original source →